Distribution of clusterin in Alzheimer brain tissue
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The immunohistochemical distribution of clusterin (SP40,40, SGP-2) was determined in Alzheimer disease (AD) and normal human brain tissue and compared with the distributions of vitronectin, protectin and the complement membrane attack complex (MAC). Antibodies to all four proteins showed staining of dystrophic neurites and neuropil threads in AD tissue, and residual serum in normal tissue, but only antibodies to clusterin and vitronectin strongly stained amyloid deposits in senile plaques. The clusterin antibody also showed punctate staining of some normal appearing AD pyramidal neurons, and very scattered staining of intracellular neurofibrillary tangles. Clusterin, vitronectin and protectin are all believed to inhibit membrane insertion by the MAC, and these data are consistent with upregulation of all three proteins in response to MAC formation in AD, and with a neuronal origin of clusterin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It interacts with the soluble form of Aβ in animal models of disease and binds soluble Aβ in a specific and reversible manner, forming complexes that have been shown to cross the blood-brain barrier [21][22][23][24] .”
From Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (2009) · cites this paper as [21]
In the citing paper
“Clusterin, which is secreted by astrocytes, has been found to complex to soluble Aβ [35], is present in plaques [36–38], and directly activates microglia [39].”
From Microglial dysfunction in brain aging and Alzheimer's disease (2014) · cites this paper as [37]
Citations
Cites
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Immune System Response in Alzheimer's Disease
McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100029863 · Cited by 459
Induction of the TRPM-2 gene in cells undergoing programmed death.
Buttyan, R., Olsson, C. A., Pintar, J., Chang, C., Bandyk, M., Ng, P. Y., & Sawczuk, I. S. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.8.3473 · Cited by 452
May, P. C., Lampert-Etchells, M., Johnson, S. A., Poirier, J., Masters, J. N., & Finch, C. E. (1990) · Neuron · doi:10.1016/0896-6273(90)90342-d · Cited by 339
Biosynthesis and molecular cloning of sulfated glycoprotein 2 secreted by rat Sertoli cells
Collard, M. W., & Griswold, M. D. (1987) · Biochemistry · doi:10.1021/bi00386a008 · Cited by 330
Murphy, B. F., Kirszbaum, L., Walker, I. D., & d'Apice, A. J. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113531 · Cited by 313
Changes in brain gene expression shared by scrapie and Alzheimer disease.
Duguid, J. R., Bohmont, C. W., Liu, N. G., & Tourtellotte, W. W. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.7260 · Cited by 251
Fritz, I. B., Burdzy, K., Sétchell, B., & Blaschuk, O. (1983) · Biology of Reproduction · doi:10.1095/biolreprod28.5.1173 · Cited by 243
Kirszbaum, L., Sharpe, J. A., Murphy, B., d'Apice, A. J., Classon, B., Hudson, P., & Walker, I. D. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03430.x · Cited by 238
Sylvester, S. R., Skinner, M. K., & Griswold, M. D. (1984) · Biology of Reproduction · doi:10.1095/biolreprod31.5.1087 · Cited by 220
Cited by
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
“In individuals with Alzheimer's disease, CLU expression is reported to be increased in affected cortical areas of the brain and to be present in amyloid plaques and in the cerebrospinal flui”
BackgroundMCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287
Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
Greenberg, S. M., Bacskai, B. J., Hernandez-Guillamon, M., Pruzin, J., Sperling, R., & van Veluw, S. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0281-2 · Cited by 947
Microglial dysfunction in brain aging and Alzheimer's disease
Mosher, K. I., & Wyss-Coray, T. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.008 · Cited by 618
“Clusterin, which is secreted by astrocytes, has been found to complex to soluble Ab [35], is present in plaques [36–38], and directly activates microglia”
Background
Metadata
- Authors
- McGeer, P. L., Kawamata, T., & Walker, D. G.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- McGeer, P.L.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 1992-05
- Volume
- 579
- Issue
- 2
- Pages
- 337-341
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W1966831712
- Cited by
- 212
- References
- 23
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 7 · 2020: 2 · 2019: 6 · 2018: 2 · 2017: 2 · 2016: 6 · 2015: 7 · 2014: 4 · 2013: 4 · 2012: 10
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Clusterin in disease pathology
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- clusterin, Alzheimer's disease, vitronectin, protectins, membrane attack complex, amyloid plaques, amyloid deposits, neurofibrillary tangles, dystrophic neurites, neuropil threads, pyramidal neurons, complement inhibition
- MeSH terms
- Aged, Alzheimer Disease, Brain, Complement System Proteins, Female, Glycoproteins, Humans, Immunohistochemistry, Male, Immunoblotting, Molecular Chaperones, Vitronectin, Clusterin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Distribution of clusterin in Alzheimer brain tissue. https://app.cochat.ai/papers/10.1016/0006-8993(92)90071-g
- The paper
- McGeer, P. L., Kawamata, T., & Walker, D. G. (1992). Distribution of clusterin in Alzheimer brain tissue. Brain Research. https://doi.org/10.1016/0006-8993(92)90071-g
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.